Cancer incidence in France over the 1980–2012 period: Hematological malignancies

Abstract

The striking differences in the incidence patterns by histologic subtype strongly suggest a certain level of etiologic heterogeneity among hematological malignancies and support the pursuit of epidemiologic analysis by subtype for HMs in international studies. Age-standardized incidence rates are essential to analyze trends in risk, whereas the number of incident cases is necessary to make provisions for healthcare resources and to evaluate the overall burden of HM.

Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux

“…The recurrence rate after an initial response was examined by the Kaplan-Meier method. The incidence rate of malignancies and the mortality rate in our cohort were compared with those of the French general population, based on Institut de Veille Sanitaire data 23,24 and INSEE data, respectively, by standardized incidence/mortality ratios.…”

“…3.2.6 | Hypogammaglobulinemia and neutropeniaGammaglobulin level was not systematically monitored. Among the 142 (52%) patients with available data, five with median age 49 years[40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57] showed profound hypogammaglobulinemia (<5 g/L) after a median of 25[15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] months after the last rituximab infusion. The median lowest gammaglobulin level in these five patients was 3.12…”

Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients

“…Therefore, some investigators believe that MDS‐associated RP should be considered a paraneoplastic syndrome , and its poor prognosis might reflect the poor prognosis of MDS per se . The fact that MDS occurred in only men in our series is striking and contrasts with the epidemiology of MDS, with a male:female ratio of ∼1.5 in France . This unexplained particularity was previously described in our center in 1995.…”

Breast cancer cases of female patients under 35�years of age in Togo: A series of 158�cases

“…Continuous and comprehensive recording of all cancer cases (cancer registry) is a guarantee of the quality of the data, and allows estimation of the incidence as well as the various epidemiological parameters (3)(4)(5)(6)(7)(8)(9). In France, the national incidence for cancer is estimated using data from the French network of cancer registries (FRANCIM) (10).…”

“…While the highest rates are recorded in the USA and Europe, they are also notably high in certain countries in South America, Asia and Africa (Brazil, Argentina, Pakistan, Kuwait and Egypt) (8,10). In the current study, the proportion of breast cancer cases under 35 years of age was 38.3%, comparable to data from the African series (11).…”